Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics: Recommendations from a panel of experts

  1. Arpino, G.
  2. Marmé, F.
  3. Cortés, J.
  4. Ricevuto, E.
  5. Leonard, R.
  6. Llombart-Cussac, A.
Zeitschrift:
Critical Reviews in Oncology/Hematology

ISSN: 1879-0461,  1040-8428

Datum der Publikation: 2016

Ausgabe: 99

Seiten: 81-90

Art: Rezension

DOI: 10.1016/J.CRITREVONC.2015.10.007 GOOGLE SCHOLAR
Datenquelle: Scopus